Healthcare -
Biotechnology - NASDAQ - US
$ 2.95
-10.3 %
$ 2.15 B
Market Cap
-3.28
P/E
IBRX - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss IBRX - ImmunityBio, Inc.
10 K
LAST VALUE
58.11%
2 YEAR CAGR
15.30%
5 YEAR CAGR
12.02%
10 YEAR CAGR